[1]
S. Mishra and R. Dahima, “IN VITRO ADME STUDIES OF TUG-891, A GPR-120 INHIBITOR USING SWISS ADME PREDICTOR”, J. Drug Delivery Ther., vol. 9, no. 2-s, pp. 366–369, Apr. 2019, doi: 10.22270/jddt.v9i2-s.2710.